BioCentury
ARTICLE | Clinical News

TKM-PLK1: Phase I/II started

August 19, 2013 7:00 AM UTC

Tekmira began an open-label Phase I/II trial to evaluate weekly TKM-PLK1 for the first 3 weeks of a 4-week cycle in about 20 patients, including >=10 GI-NET patients. The company said it aims to start...